Tenet Healthcare Stock
Tenet Healthcare Stock
We can see a decrease in the price for Tenet Healthcare. Compared to yesterday it has lost -€6.000 (-2.700%).
With 45 Buy predictions and not a single Sell prediction Tenet Healthcare is an absolute favorite of our community.
On the other hand, the target price of 217 € is below the current price of 218.0 € for Tenet Healthcare, so the potential is actually -0.46%.
Pros and Cons of Tenet Healthcare in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tenet Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tenet Healthcare | -2.700% | 7.767% | 32.143% | 62.044% | 27.586% | 217.143% | 265.854% |
| Chemed Corp. | -0.430% | 3.139% | 9.524% | 27.778% | 26.374% | - | - |
| Davita Inc. | 3.120% | 0.531% | 3.892% | 73.935% | 115.886% | 123.295% | 105.325% |
| Molina Healthcare | -0.290% | -2.359% | -17.017% | 26.595% | 16.233% | -38.268% | -26.281% |
Comments
Tenet Healthcare (THC) had its "overweight" rating reaffirmed by Wells Fargo & Company.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare (THC) had its price target raised by Truist Financial Corporation from $270.00 to $290.00. They now have a "buy" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare (THC) was given a new $308.00 price target by UBS Group AG. They now have a "buy" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat